Subjects were aged 51–100 years, diagnosed with iAMD in at least one eye. All subjects had the capacity to sign informed consent and complete the study questionnaire.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.